iTRAQ and PRM-Based Proteomic Analysis Provides New Insights into Mechanisms of Response to Triple Therapy in Patients with Rheumatoid Arthritis

Abstract

Serotransferrin-related molecular mechanism may be a new direction to study refractory RA.